FDA Inspection 1148500 — Nnodum Pharmaceuticals

Nnodum Pharmaceuticals — FEI 3010392264

The FDA completed an inspection of Nnodum Pharmaceuticals on August 5, 2021 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 5, 2021
Fiscal Year
2021
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Cincinnati, OH (United States)

Citations

IDCFRDescription
1592721 CFR 111.103Written procedures - quality control operations